Cite

HARVARD Citation

    Krieg, C. et al. (2022). Complement downregulation promotes an inflammatory signature that renders colorectal cancer susceptible to immunotherapy. Journal for immunotherapy of cancer. 10 (9), p. . [Online]. 
  
Back to record